title: Clinical disintegration time of orally disintegrating tablets clinically available in Japan in healthy volunteers.
abstract: Disintegration time is an important characteristic of orally disintegrating tablets (ODTs), and evaluation of disintegration time is a key step in formulation development, manufacturing, and clinical practice. In this study, we aimed to clarify the clinical disintegration time of ODTs that are currently used clinically, and to evaluate its correlation with the in vitro disintegration time of ODTs which was measured using Tricorptester, a newly developed disintegration testing apparatus. The clinical disintegration time of 17 ODT products was measured in healthy volunteers (n=9-10; age range, 21-28 years). A randomized single-blind trial was performed; each tablet was placed on the tongues of the participants, and it disintegrated in their oral cavities. No significant difference was observed in the clinical disintegration time of each ODT among the 3 groups to which the subjects were randomly assigned. The clinical disintegration time of the 17 ODT products was between 17.6 s and 33.8 s. The in vitro disintegration time of 26 clinically used ODT products measured using Tricorptester ranged between 4.40 s and 30.4 s. A significant positive correlation was observed between in vitro and clinical disintegration times (r=0.79; p<0.001). This study shows that all the tested products, which are clinically available in Japan, showed good disintegration and that the disintegration time varied according to the product. In addition, the in vitro disintegration time of ODTs measured using Tricorptester is a good reflection of the disintegration time in the oral cavity.
authors.affiliation: Department of Pharmacy Practice and Science, School of Pharmaceutical Sciences University of Shizuoka.
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Yoshita
authors.forename: Shinya
authors.initials: S
authors.lastname: Uchida
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Namiki
mesh_terms: D000284:Administration, Oral; D000328:Adult; D064368:Healthy Volunteers; D006801:Humans; D007564:Japan; D009055:Mouth; D004364:Pharmaceutical Preparations / Q000008:administration & dosage / Q000737:chemistry; D016037:Single-Blind Method; D012995:Solubility; D013607:Tablets / Q000008:administration & dosage / Q000737:chemistry*; D013678:Technology, Pharmaceutical / Q000295:instrumentation*; D055815:Young Adult
chemical_list: D004364:Pharmaceutical Preparations; D013607:Tablets